Left Menu
Development News Edition

UPDATE 3-Purdue Pharma reaches tentative opioid settlement -sources

Reuters | Washington DC | Updated: 12-09-2019 01:13 IST | Created: 12-09-2019 01:12 IST
UPDATE 3-Purdue Pharma reaches tentative opioid settlement -sources
Image Credit: Flickr

OxyContin maker Purdue Pharma LP reached a tentative agreement with some plaintiffs to resolve widespread litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states opposing its settlement offer in bankruptcy proceedings starting as soon as next week, people familiar with the matter said. On Wednesday, lead lawyers representing more than 2,000 cities, counties and other plaintiffs suing Purdue, along with 26 states and U.S. territories, were on board with an offer from the company and its controlling Sackler family to settle lawsuits in a deal valued at up to $12 billion, the people said.

More than a dozen other states remain opposed or uncommitted to the deal, setting the stage for a legal battle over Purdue's efforts to contain the litigation in bankruptcy court, they said. States on Wednesday updated a federal judge on the settlement offer's support, which remained in flux and could evolve as the day progresses, the people said.

Purdue's board is scheduled to be briefed on settlement progress on Thursday, one of the people said. There remained a chance negotiations could fall apart and the company's plans, including the timing of a bankruptcy filing, could change, the person said. Reuters earlier on Wednesday reported that Purdue was nearing a settlement with cities and many states.

The Sacklers, well-known wealthy philanthropists, have declined to revise their proposed settlement contribution of $3 billion over seven years and another $1.5 billion or more through the eventual sale of another business they own called Mundipharma, several people familiar with the matter said. New York, Massachusetts and Connecticut, where privately-held Purdue is based, are among the states opposed to the current offer and have pushed the family to guarantee $4.5 billion, the people said.

Last weekend, the Sacklers "refused to budge" after attorneys general in North Carolina and Tennessee presented the family with counterproposals they said had widespread support from other states, according to correspondence reviewed by Reuters. The lawsuits, which have in some cases targeted the Sacklers as well as Purdue, claim the family and company contributed to a public health crisis that claimed the lives of nearly 400,000 people between 1999 and 2017, according to the latest data from the U.S. Centers for Disease Control and Prevention.

The suits allege Purdue aggressively marketed prescription painkillers while misleading doctors and patients about their addiction and overdose risks. Purdue and the Sacklers have denied the allegations.

FAMILY CONTRIBUTION A STICKING POINT

With negotiations over the family's contribution to a settlement at loggerheads, Purdue is preparing to file for bankruptcy protection as soon as this weekend or next with the outlines of a settlement in hand, albeit one lacking support from many states, the people said. Purdue would then ask a U.S. bankruptcy judge to halt litigation while settlement discussions continue, a move some states are likely to challenge, they said. A bankruptcy judge could force holdouts to accept a settlement as part of Purdue's reorganization plan if enough other plaintiffs agree.

"The family supports working toward a global resolution that directs resources to the patients, families and communities across the country who are suffering and need assistance," members of the Sackler family targeted in lawsuits said in a statement. "This is the most effective way to address the urgency of the current public health crisis, and to fund real solutions, not endless litigation," the statement added.

Purdue had no immediate comment. With Purdue facing more than 2,000 opioid-related lawsuits, Reuters reported in March that the company and the Sacklers began exploring bankruptcy options to halt litigation and attempt to reach a far-reaching settlement rather than fight every case individually.

One reason Purdue is eyeing a bankruptcy filing soon is to avoid an Oct. 21 trial, the people said. That trial, stemming from widespread lawsuits largely brought by local governments that have been consolidated in an Ohio federal court, risks a verdict with outsize damages Purdue could not withstand, one of the people said. Purdue's current proposal envisions it using bankruptcy proceedings to transform into a public trust with a board selected by court-appointed trustees, the people said. The trust would donate drugs the company developed to combat overdoses and addiction to U.S. communities, which Purdue values at $4.45 billion over 10 years.

The Sacklers, who amassed a multibillion-dollar fortune from OxyContin sales, would cede control of Purdue, they said. A Chapter 11 filing with a deal many states oppose risks triggering even more litigation and longer, more expensive bankruptcy proceedings that could reduce payouts to plaintiffs unless a broader deal is reached.

"I remain steadfast in my view that the Sacklers have to give back the money they took from selling opioids so that we can put it toward solving the problem they created," Connecticut Attorney General William Tong said in a statement provided to Reuters. "The current proposal does not do that." The Sacklers have rebuffed requests from some plaintiffs for more details on the family's finances to address concerns more settlement money could be available, some of the people said.

North Carolina Attorney General Josh Stein said he was not satisfied with Purdue's position and was preparing to follow other state officials and sue the Sacklers. "A large number of states are committed to the notion that the Sacklers need to guarantee more money," he said, adding that different states "have different views, as is to be expected."


TRENDING

OPINION / BLOG / INTERVIEW

Post-COVID-19 Nigeria needs a robust Health Management Information System to handle high disease burden

Nigeria is among a few countries that conceptualised a health management information system HMIS in the early 90s but implementation has been a challenge till date. Besides COVID-19, the country has a huge burden of communicable and non-com...

Morocco COVID-19 response: A fragile health system and the deteriorating situation

Learning from its European neighbors, Morocco imposed drastic measures from the initial stages of the COVID-19 outbreak to try to contain its spread. The strategy worked for a few months but the cases have surged after mid-June. In this sit...

COVID-19: Argentina’s health system inefficiencies exaggerate flaws of health information system

You can recover from a drop in the GDP, but you cant recover from death, was the straightforward mindset of Argentinas President Alberto Fernndez and defined the countrys response to COVID-19. The South American nation imposed a strict...

Rwanda’s COVID-19 response commendable but health information system needs improvement

Rwanda is consistently working to improve its health information system from many years. However, it is primarily dependent on the collection and reporting of health data on a monthly basis. Besides, evaluation studies on Rwandas HIS publis...

Videos

Latest News

GLOBAL MARKETS-Shares, currencies tentative as attention shifts to U.S. election, stimulus

Asian shares held to tight ranges on Monday, as did currencies, as investors awaited developments on U.S. fiscal stimulus and coronavirus vaccines amid a resurgence of infections in Europe. MSCIs broadest index of Asia-Pacific shares outsid...

Butker kicks Chiefs to OT win over Chargers

Patrick Mahomes passed for two touchdowns, and Harrison Butkers franchise record-tying 58-yard field goal in overtime spoiled Justin Herberts impressive debut, as the Kansas City Chiefs beat the AFC West-rival Los Angeles Chargers 23-20 on ...

PRESS DIGEST-Financial Times - Sept 21

The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. HeadlinesECB to review flagship bond-buying tool in fighting Covid crisis httpson.ft.com3hQvp3T Sunak to...

FEATURE -Job or hijab? Singapore debates ban on Islamic veil at work

By Beh Lih Yi Sept 21 Thomson Reuters Foundation - Every day before she starts her shift at a government hospital in Singapore, Farah removes her hijab - the Islamic veil she has worn since a teenager.Although minority Muslim women can free...

Give Feedback